KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Cash from Financing Activities (2016 - 2025)

Chemed (CHE) has 17 years of Cash from Financing Activities data on record, last reported at -$172.8 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 18.67% year-over-year to -$172.8 million; the TTM value through Dec 2025 reached -$432.8 million, down 20.48%, while the annual FY2025 figure was -$432.8 million, 20.48% down from the prior year.
  • Cash from Financing Activities reached -$172.8 million in Q4 2025 per CHE's latest filing, up from -$189.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$263000.0 in Q3 2023 and bottomed at -$212.5 million in Q4 2024.
  • Average Cash from Financing Activities over 5 years is -$73.1 million, with a median of -$50.3 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: soared 99.34% in 2023, then crashed 21365.02% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$45.4 million in 2021, then soared by 68.34% to -$14.4 million in 2022, then surged by 57.64% to -$6.1 million in 2023, then tumbled by 3392.1% to -$212.5 million in 2024, then rose by 18.67% to -$172.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$172.8 million in Q4 2025, -$189.3 million in Q3 2025, and -$47.1 million in Q2 2025.